Intercure (XTAE:INCR) Institutional Ownership : 2.87% (As of May. 08, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Intercure Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intercure's institutional ownership is 2.87%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intercure's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intercure's Float Percentage Of Total Shares Outstanding is 54.82%.

Intercure Institutional Ownership Historical Data

The historical data trend for Intercure's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Institutional Ownership Chart

Intercure Historical Data

The historical data trend for Intercure can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	4.56	3.83	3.97	3.87	3.02	2.95	2.78	2.84	2.87	2.87

Intercure Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Intercure (XTAE:INCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

INCR:USA

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.